Protease Inhibitor-Induced Diabetic Complications: Incidence, Management and Prevention

Author： Lien Lillian F.   Feinglos Mark N.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.3, 2005-01, pp. : 209-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE Inhibitor-Induced Angioedema: Incidence, Prevention and Management

By Vleeming W.  

Drug Safety, Vol. 18, Iss. 3, 1998-03 ,pp. : 171-188

Adis International

Access to resources Recommend Favorite

Serotonin Reuptake Inhibitor-Induced Perinatal Complications

By Gentile Salvatore  

Pediatric Drugs, Vol. 9, Iss. 2, 2007-01 ,pp. : 97-106

Adis International

Access to resources Recommend Favorite

Rosuvastatin is effective and well tolerated in the treatment of protease inhibitor-induced hyperlipidaemia

By  

Reactions Weekly, Vol. 1, Iss. 1062, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Drug-Induced Parkinsonism in the Elderly: Incidence, Management and Prevention

By López-Sendón José Luis   Mena María Angeles   de Yébenes Justo García  

Drugs & Aging, Vol. 29, Iss. 2, 2012-02 ,pp. : 105-118

Adis International

Access to resources Recommend Favorite

Lactic Acidosis Induced by Metformin: Incidence, Management and Prevention

By Lalau Jean-Daniel  

Drug Safety, Vol. 33, Iss. 9, 2010-09 ,pp. : 727-740

Adis International

Access to resources Recommend Favorite